Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Tamoxifen 20mg Tablet
Therapeutic Category
Oncology, Anticancer, Gynecology and Fertility
Dosage Form
Tablet
Packaging Type
Blister
Packaging
10*10
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Tamotreat 20 Tablet (Tamoxifen 20 mg) is an established and indispensable oral medication in oncology, classified as a Selective Estrogen Receptor Modulator (SERM). It is the cornerstone of endocrine therapy for patients with Hormone Receptor-Positive (ER+/PR+) breast cancer.
Mechanism and Impact:Tamoxifen primarily works by binding to estrogen receptors on breast cancer cells, acting as an anti-estrogen, thereby blocking estrogen's proliferative effects. This crucial mechanism makes it highly effective in reducing the risk of recurrence and mortality in patients following primary treatment. It is typically prescribed for long-term use, lasting 5 to 10 years.
Key Therapeutic Uses:
Adjuvant Therapy: Reducing recurrence and improving overall survival in patients with early-stage ER+breast cancer.
Metastatic Disease: Treatment of advanced or metastatic ER+breast cancer.
Risk Reduction: Approved for reducing breast cancer incidence in high-risk women.
Due to the essential nature and the prescribed 5-10 year duration of treatment, Tamoxifen 20 mg guarantees exceptionally high, stable, and long-term prescription volume. We offer an exclusive PCD Pharma Franchise opportunity for Tamocare 20 Tablet, enabling partners to dominate the foundational segment of the ER+breast cancer market.
Possible side effects include stomach upset, nausea, dizziness, or diarrhea. Rarely, allergic reactions or gastrointestinal bleeding may occur.
Tamotreat 20 Tablet is indicated for the relief of mild to moderate pain and inflammation, including headaches, menstrual pain, and musculoskeletal pain.
Use this medication as prescribed by your doctor. Avoid exceeding the recommended dosage. Inform your doctor of any existing medical conditions or ongoing medications.
Store the suspension in a cool, dry place, away from direct sunlight. Shake well before use. Keep out of reach of children.
Composition : Paracetamol (250mg/5ml)
Composition : Ibuprofen (100mg) + Paracetamol (125mg)
Composition : Paracetamol (1000mg) Infusion
Composition : Ketorolac (30mg) Injection
Composition : Mefenamic Acid (100mg) + Paracetamol (250mg)
Composition : Mefenamic Acid (50mg) + Paracetamol (125mg)
Composition : Diclofenac diethylamine (1.16% w/v) + Linseed Oil (3% w/v) + Methyl Salicylate (10% w/v) + Menthol (5% w/v)
Composition : Diclofenac diethylamine (1.16% w/w) + Thiocolchicoside (0.125% w/w) + Linseed Oil (3.0% w/w) + Methyl Salicylate (10.0% w/w) + Menthol (5.0% w/w)
Composition : Choline Salicylate (8.7% w/w) + Lidocaine (2.0% w/w) + Benzalkonium Chloride (0.01% w/w) Gel
Composition : Flupirtine (100mg)
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Tamoxifen 20mg Tablet has strong demand in the oncology, breast cancer management, and specialty healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on oncology and specialty pharmaceutical portfolios.
Medical distributors and agencies can benefit from consistent demand for hormone therapy in breast cancer management under specialist medical supervision. Tamoxifen 20mg is a Selective Estrogen Receptor Modulator (SERM) that blocks the effects of estrogen in breast tissue Commonly prescribed for the treatment of hormone receptor-positive (ER-positive) breast cancer and to reduce the risk of recurrence following primary treatment, as advised by oncologists It is also used to reduce the risk of developing breast cancer in women at high risk, when considered appropriate by healthcare professionals Helps slow or prevent the growth of estrogen-dependent breast cancer cells, supporting long-term disease management Oral tablet formulation offers convenient once-daily administration and supports patient adherence to long-term therapy Requires regular medical supervision, including periodic monitoring for treatment response and potential adverse effects throughout therapy Frequently utilized in oncology centers, breast cancer clinics, hospitals, and specialty healthcare facilities Widely prescribed by medical oncologists, surgical oncologists, and gynecologic oncologists This strengthens a comprehensive oncology and women's healthcare portfolio.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Tamoxifen 20mg Tablet with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from consistent specialty prescription demand, long-term therapy requirements, oncology market opportunities, reliable supply chain support, repeat procurement, and attractive margins in the oncology segment.
Interested distributors, stockists, wholesalers, and institutional suppliers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality oncology products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.